Oragenics Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.3807 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.2184 - 0.7699
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.3807 USD


Draw Mode:

Oragenics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 44.31M 116.39M 113.70M $ 86.99k $ - -0.14 -2.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.78M 6.20%

more financials information »

Oragenics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.360.39020.360.377371190,2750.02075.75%
1 Month0.350.400.3230.3640218257,5800.03078.77%
3 Months0.29590.400.26510.3358817308,8210.084828.66%
6 Months0.40650.420.21840.3449335533,850-0.0258-6.35%
1 Year0.63310.76990.21840.54085211,402,432-0.2524-39.87%
3 Years0.38692.120.21840.84592484,906,372-0.0062-1.6%
5 Years3.486.800.21840.94933643,626,695-3.10-89.06%

Oragenics Description

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now